| [1] |
Blumberg BS, Alter HJ, Visnich S. A “new” antigen in leukemia sera. JAMA, 1965, 191:541-546.
|
| [2] |
Blumberg BS, Sutnick AI, London WT. Hepatitis and leukemia: their relation to Australia antigen. Bull NY Acad Med, 1968, 44:1566-1586.
|
| [3] |
Prince AM. Relation of Australia and SH antigens. Lancet, 1968, 2:462-463.
|
| [4] |
Dragosics B, Ferenci P, Hitchman E, et al. Long-term followup study of asymptomatic HBsAg-positive voluntary blood donors in Austria: a clinical and histologic evaluation of 242 cases. Hepatology, 1987, 7:302-306.
|
| [5] |
Hadziyannis S, Merikas G, Panetsos S, et al. Hepatitis associated antigen carriers among blood donors in Greece. Am J Dis Child, 1972, 123:381-383.
|
| [6] |
Velasco M, Gonzalez-Ceron M, de la Fuente C, et al. Clinical and pathological study of asymptomatic HBsAg carriers in Chile. Gut, 1978, 19:569-571.
|
| [7] |
Villeneuve JP, Desrochers M, Infante-Rivard C, et al. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology, 1994, 106:1000-1005.
|
| [8] |
Eleftheriou N, Thomas HC, Heathcote J, et al. Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease. Lancet, 1975, 2:1171-1173.
|
| [9] |
Hadziyannis SJ, Vassilopoulos D. Hepatitis B e antigen-negative chronic hepatitis B. Hepatology, 2001, 34:617-624.
|
| [10] |
Montazeri G, Rahban M, Mohamadnejad M, et al. Liver Histology and HBV DNA levels in chronically HBV infected patients with persistently normal alanine aminotransferase. Arch Iran Med, 2010, 13: 193-202.
|
| [11] |
中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2010年版). 肝脏, 2011, 16: 2-16.
|
| [12] |
中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015更新版) . 肝脏, 2015, 20: 915-932.
|
| [13] |
Liaw YF, Kao JH, Piratvisuth T, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol Int, 2012, 6:531-561.
|
| [14] |
Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update . Hepatol Int, 2016, 10:1-98.
|
| [15] |
EASL clinical practice guidelines: management of chronic hepatitis B virus infection . J Hepatol, 2012, 57:167-185.
|
| [16] |
Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology, 2009, 50:661-662.
|
| [17] |
Terrault NA, Bzowej NH, Chang KM, et al. AASLD guidelines for treatment of chronic hepatitis B. Hepatology, 2016, 63:261-283.
|
| [18] |
杨绍基. 感染与免疫//杨绍基, 任红. 传染病学. 7版. 北京: 人民卫生出版社, 2009: 1-4.
|
